BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Staging
1660 results:

  • 1. Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.
    Schindler P; Kaldewey D; Rennebaum F; Trebicka J; Pascher A; Wildgruber M; Köhler M; Masthoff M
    J Cancer Res Clin Oncol; 2024 May; 150(5):235. PubMed ID: 38710956
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
    Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
    Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
    BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
    Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
    Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
    [No Abstract]    [Full Text] [Related]  

  • 6. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
    Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
    [No Abstract]    [Full Text] [Related]  

  • 7. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
    Iwai Y; Agala CB; Gerber DA
    JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
    O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
    Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Preoperative predictors for non-resectability in perihilar cholangiocarcinoma.
    Otto CC; Mantas A; Heij LR; Heise D; Dewulf M; Lang SA; Ulmer TF; Dahl E; Bruners P; Neumann UP; Bednarsch J
    World J Surg Oncol; 2024 Feb; 22(1):48. PubMed ID: 38326854
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.
    Bektaş M; Işık EG; Oğuz E; Kemik F; Abbasgholizadeh A; İnce B; Özkan ZG; Yalçınkaya Y; Artım-Esen B; Gül A; İnanç M
    Clin Exp Rheumatol; 2024 Feb; 42(2):358-366. PubMed ID: 38293968
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
    Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
    [No Abstract]    [Full Text] [Related]  

  • 12. Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.
    Jeong B; Lee YW; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Gwark S; Shin HJ; Yoo TK; Choi SH
    Eur J Radiol; 2024 Feb; 171():111295. PubMed ID: 38241854
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate-and advanced-stage liver cancer].
    Li R; Li WL; Yuan GS; Pang HJ; Li Q; Hu XY; Guo YB; Chen JZ; Zang MY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1163-1168. PubMed ID: 38238949
    [No Abstract]    [Full Text] [Related]  

  • 14. Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product.
    Fujita K; Morishita A; Oura K; Ono M; Himoto T; Masaki T
    Sci Rep; 2024 Jan; 14(1):1052. PubMed ID: 38200049
    [TBL] [Abstract] [Full Text] [Related]  

  • 15.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma.
    He Y; Luo L; Shan R; Qian J; Cui L; Wu Z; Tu S; Zhang W; Lin W; Tang H; Huang Z; Li Z; Mao S; Li H; Hu Z; Liu L; Shen W; He K; Li Y
    J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237069. PubMed ID: 38118280
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
    Hojo Y; Ishida Y; Tomita T; Kurahashi Y; Nakamura T; Kitayama Y; Nakao E; Kohno S; Murakami M; Takeuchi J; Takagawa T; Hirota S; Shinohara H
    Eur J Surg Oncol; 2024 Feb; 50(2):107314. PubMed ID: 38101115
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
    Yin L; Yin AH; Pu CC
    BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
    Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
    BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
    Huang S; Song JL; Li B; Yi PS; Yang J
    BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 83.